If you are questioning your current regimen, here are seven signs that it's time to change your eczema treatment.

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main goal of a phase 2 trial.

On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD study for rezpegaldesleukin, which is an eczema treatment.

Feet Treatment for Cracked Heels!! Trump gushes over Netanyahu after Nobel Peace Prize nomination: ‘An honour coming from you’ Expert Mechanic's Guide: 6 SUVs to Skip Buying A major defence ...

Eczema or psoriasis? Managing eczema in summertime Moisturizer to reduce eczema flares Nickel allergy Severe atopic dermatitis Eye problems can be a fact of life for anyone living with atopic ...

Specific allergen immunotherapy is a treatment that involves a course of injections or drops under the tongue containing the substance to which a person is allergic. The treatment can reduce the ...

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Both agents reduced the DASI by approximately 50% after 2 weeks of treatment. However, tacrolimus had no effect on plantar dyshidrotic eczema.

Dyshidrotic eczema or dyshidrosis is a common, chronic, and recurrent eruption of small (1-2 mm) vesicles on the palms, soles, and/or lateral aspects of the fingers.